Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

This study explores the complementary or synergistic effects of medicinal cannabis constituents, particularly terpenes, concerning their therapeutic potential, known as the entourage effect. A systematic review of the literature on cannabis “entourage effects” was conducted using the PRISMA model. Two research questions directed the review: (1) What are the physiological effects of terpenes and terpenoids found in cannabis? (2) What are the proven “entourage effects” of terpenes in cannabis? The initial approach involved an exploratory search in electronic databases using predefined keywords and Boolean phrases across PubMed/MEDLINE, Web of Science, and EBSCO databases using Medical Subject Headings (MeSH). Analysis of published studies shows no evidence of neuroprotective or anti-aggregatory effects of α-pinene and β-pinene against β-amyloid-mediated toxicity; however, modest lipid peroxidation inhibition by α-pinene, β pinene, and terpinolene may contribute to the multifaceted neuroprotection properties of these C. sativa L. prevalent monoterpenes and the triterpene friedelin. Myrcene demonstrated anti-inflammatory proprieties topically; however, in combination with CBD, it did not show significant additional differences. Exploratory evidence suggests various therapeutic benefits of terpenes, such as myrcene for relaxation; linalool as a sleep aid and to relieve exhaustion and mental stress; D-limonene as an analgesic; caryophyllene for cold tolerance and analgesia; valencene for cartilage protection; borneol for antinociceptive and anticonvulsant potential; and eucalyptol for muscle pain. While exploratory research suggests terpenes as influencers in the therapeutic benefits of cannabinoids, the potential for synergistic or additive enhancement of cannabinoid efficacy by terpenes remains unproven. Further clinical trials are needed to confirm any terpenes “entourage effects.”

Details

Title
The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review
Author
André, Rebeca 1   VIAFID ORCID Logo  ; Ana Patrícia Gomes 2 ; Pereira-Leite, Catarina 3   VIAFID ORCID Logo  ; Marques-da-Costa, António 4 ; Luis Monteiro Rodrigues 1   VIAFID ORCID Logo  ; Sassano, Michael 4 ; Rijo, Patricia 5   VIAFID ORCID Logo  ; Maria do Céu Costa 6   VIAFID ORCID Logo 

 Escola de Ciências e Tecnologias da Saúde (ECTS), CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal; [email protected] (R.A.); [email protected] (A.P.G.); [email protected] (C.P.-L.); [email protected] (L.M.R.) 
 Escola de Ciências e Tecnologias da Saúde (ECTS), CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal; [email protected] (R.A.); [email protected] (A.P.G.); [email protected] (C.P.-L.); [email protected] (L.M.R.); SOMAÍ Pharmaceuticals, R. 13 de Maio 52, 2580-507 Carregado, Portugal; [email protected] (A.M.-d.-C.); 
 Escola de Ciências e Tecnologias da Saúde (ECTS), CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal; [email protected] (R.A.); [email protected] (A.P.G.); [email protected] (C.P.-L.); [email protected] (L.M.R.); Laboratório Associado para a Química Verde, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal 
 SOMAÍ Pharmaceuticals, R. 13 de Maio 52, 2580-507 Carregado, Portugal; [email protected] (A.M.-d.-C.); 
 Escola de Ciências e Tecnologias da Saúde (ECTS), CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal; [email protected] (R.A.); [email protected] (A.P.G.); [email protected] (C.P.-L.); [email protected] (L.M.R.); Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal 
 Escola de Ciências e Tecnologias da Saúde (ECTS), CBIOS—Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal; [email protected] (R.A.); [email protected] (A.P.G.); [email protected] (C.P.-L.); [email protected] (L.M.R.); NICiTeS, Polytechnic Institute of Lusophony, ERISA-Escola Superior de Saúde Ribeiro Sanches, Rua do Telhal aos Olivais 8, 1950-396 Lisboa, Portugal 
First page
1543
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
14248247
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3133138029
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.